BCL2 and ovarian cancer: Specifically, Bcl-2, recognized as the prototypical anti-apoptotic protein, is overexpressed in a number of solid tumors, including ovarian cancer, and contributes to neoplastic transformation through inhibition of apoptosis [15], thereby promoting tumor survival.